Open original FDA record ↗Recall record
- FDA identifier
- Z-1178-2014
- Company in FDA record
- Lin-Zhi International Inc
- FDA classification date
- Mar 12, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Product catalog #s 0007c Cannabinoid 37.5 ng/mL Control Level 1 and 0008c Cannabinoid 62.5 Control Level 2 of the lots mentioned may give decreased concentration readings towards the end of their shelf life due to use of dated but unexpired secondary stock used to create the products.
Source facts
- Action
- Lin-Zhi International, sent an Recall letter dated February 6, 2014, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. The Recall letter identified the product by catalog number and product description as well as lot numbers. The reason for recall is explained and that the issue was confirmed by Lin Zhi Quality Control. The 2 affected lots were made with unexpired but dated secondary stock that is the cause of the problem. Lin Zhi requests that customers inform laboratories and customers to properly dispose of any of the affected lots that are still in use or unopened. Lin Zhi should be notified of the amounts for credit. Questions should be directed to 408-732-3883.
- Initiated
- 2014-02-06
- Root cause
- Nonconforming Material/Component
- Terminated
- 2015-03-10
- Distribution
- US Distribution including the states of SC, NC, LA, FL, TX,, AL and GA and Internationally to Germany.
- Recall number
- Z-1178-2014
- Recall status
- Terminated
- CDRH record ID
- 125666
- FDA classified
- 2014-03-12
- Recall event number
- 67521